temozolomide,capecitabine
Not Tagged
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'crcsm', 'prodige23']
prodige23 tnt continues to show long term benefit in all survival endpoints over soc. now the question is how to best do it which patients really need folfirinox? #asco23 #crcsm 
GI Oncologist at @IUCancerCenter. @uw_hemeoncpc and @UChicagomed alum. Tweets are my own.